Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone-iodine + dexamethasone sodium phosphate + isopropyl alcohol + bupivacaine hydrochloride
- Development stage
- Unknown
- Lead developer
- Asclemed USA
- Modality
- Small Molecules
- Administration
- Epidural, Infiltration, Intraarticular, Intralesional, Intramuscular, Topical
01
Overview
povidone-iodine + dexamethasone sodium phosphate + isopropyl alcohol + bupivacaine hydrochloride is a marketed multi-component pharmaceutical kit sold as DEXLIDO-M KIT and distributed by Asclemed USA for procedural local or regional anesthesia and analgesia. The product combines **bupivacaine hydrochloride**, an amide-type small-molecule local anesthetic that blocks voltage-gated sodium channels and thereby prevents initiation and conduction of nerve impulses; **dexamethasone sodium phosphate**, a corticosteroid prodrug that activates the glucocorticoid receptor to provide anti-inflammatory effects; and the antiseptic skin-preparation agents **povidone-iodine** and **isopropyl alcohol**, which reduce microbial burden before injection or surgery. Based on the supplied context, the kit is used across procedural settings including surgery, diagnostic and therapeutic procedures, with administration involving injectable anesthetic/steroid components and topical antiseptic application.
- Brand names
- DEXLIDO-M KIT
- Other names
- povidone-iodine + dexamethasone sodium phosphate + isopropyl alcohol + bupivacaine hydrochloride
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on povidone-iodine + dexamethasone sodium phosphate + isopropyl alcohol + bupivacaine hydrochloride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on povidone-iodine + dexamethasone sodium phosphate + isopropyl alcohol + bupivacaine hydrochloride.